California Cancer Reporting System Standards, Volume III
CoC
California Hospital Transmit
Eureka Admission Level
Eureka Tumor Level
Regional Nodes Positive [NAACCR #820]
TNM Path N [NAACCR #890]
Date of Diagnosis [NAACCR #390]
Primary Site [NAACCR #400]
Histologic Type ICD-O-3 [NAACCR #522]
Behavior Code ICD-O-3 [NAACCR# 523]
CS Site-Specific Factor 10 [NAACCR #2864]
CS Site-Specific Factor 25 [NAACCR #2879]
Grade [NAACCR #440]
Age at Diagnosis [NAACCR #230]
Sex [NAACCR #220]
Type of Reporting Source [NAACCR# 500]
AC7G2016.DBF
PATHNNUM.DBF
IF1203: TNM Path N of [value] is not consistent with Regional Nodes Positive of [value]
This edit is skipped if any of the following conditions are true:
Year of Date of Diagnosis is less than 2016, blank unknown), or invalid
Type of Reporting Source = 7 (Death Certificate Only)
Histologic Type ICD-O-3 is blank
Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)
Site/Histology where Path N is not dependent on number of positive nodes
TNM Path N is blank or 88
Regional Nodes Positive is empty
Regional Nodes Positive is coded "95", "Positive aspiration of lymph nodes performed".
Regional Nodes Positive is coded "97", "Positive nodes are documented but the number is unspecified".
TNM Edition Number not = 07, U7
TNM Path Descriptor = 4, 6
TNM Path N may be blank. If entered, it will be edited site-specifically. A pN category entered in TNM Path N will be compared to Regional Nodes Positive. An edit failure will be returned if the number of positive nodes is outside the range of positive nodes for the listed pN category. "90", "90 or more nodes are positive", is the highest possible number of positive nodes.
The site-specific TNM Pathologic N values with the corresponding number of positive regional nodes are listed below. The number next to each site title indicates the respective chapter in the AJCC Cancer Staging Manual, Edition 7. The list includes only those sites/histology groups where pathologic N is based on the number of positive regional nodes. The site/histology groups are identified by site and histology in the edits Primary Site, AJCC Stage Group 2016 - Ed 7 (COC), Primary Site, Stage Group 2016 - Ed 7 (NPCR), and Primary Site, Stge Group 2016 - Ed 7 (SEER).
Lip and Oral Cavity
TNM N |
1,2A |
2B |
Reg Nodes Pos |
01-01 |
02-90 |
Pharynx
Oropharynx and Hypopharynx
Oropharynx only
TNM N |
1,2A |
2B |
Reg Nodes Pos |
01-01 |
02-90 |
Larynx
Supraglottis, Subglottis, Other
Glottis
TNM N |
1,2A |
2B |
Reg Nodes Pos |
01-01 |
02-90 |
Nasal Cavity and Paranasal Sinuses
TNM N |
1,2A |
2B |
Reg Nodes Pos |
01-01 |
02-90 |
Major Salivary Glands
TNM N |
1,2A |
2B |
Reg Nodes Pos |
01-01 |
02-90 |
Esophagus and Esophagus Gastric Junction
Esophagus
Esophagus Gastric Junction
TNM N |
1 |
2 |
3 |
Reg Nodes Pos |
01-02 |
03-06 |
07-90 |
Stomach
TNM N |
1 |
2 |
3 |
3A |
3B |
Reg Nodes Pos |
01-02 |
03-06 |
>06 |
07-15 |
16-19 |
Small Intestine
TNM N |
1 |
2 |
Reg Nodes Pos |
01-03 |
04-90 |
Appendix
Appendix: Carcinoma
TNM N |
1 |
2 |
Reg Nodes Pos |
01-03 |
04-90 |
Colon and Rectum
TNM N |
1 |
1A |
1B |
2 |
2A |
2B |
Reg Nodes Pos |
01-03 |
01-01 |
02-03 |
04-90 |
04-06 |
07-90 |
Cutaneous Squamous Cell Carcinoma and other Cutaneous Carcinomas
TNM N |
1,2A |
2B |
Reg Nodes Pos |
01-01 |
02-90 |
Melanoma and Skin
TNM N |
1 |
1A |
1B |
2A |
2B |
Reg Nodes Pos |
01-01 |
01-01 |
01-01 |
02-03 |
02-03 |
Breast
TNM N |
1A |
2A |
Reg Nodes Pos |
01-03 |
04-09 |
Vulva
TNM N |
1 |
1A |
1B |
2A |
2B |
Reg Nodes Pos |
01-02 |
01-02 |
01-01 |
03-90 |
02-90 |
Penis
TNM N |
1 |
2 |
Reg Nodes Pos |
01-01 |
02-90 |
Testis
TNM N |
1 |
Reg Nodes Pos |
01-05 |
Renal Pelvis and Ureter
TNM N |
1 |
Reg Nodes Pos |
01-01 |
Urinary Bladder
TNM N |
1 |
2 |
Reg Nodes Pos |
01-01 |
02-90 |
Urethra
TNM N |
1 |
Reg Nodes Pos |
01-01 |
08/2016 |
Per NAACCR v16, new edit added. |
09/2016 |
Per NAACCR v16A:
|
11/2016 |
Per NAACCR v16B:
|
03/2017 |
Per NAACCR v16D:
|